World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
119
Citations
54291
World Ranking
3888
National Ranking
152

Rudolf A. de Boer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rudolf A. de Boer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 598 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rudolf A. de Boer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rudolf A. de Boer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 119 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rudolf A. de Boer is affiliated with the University Medical Center Groningen in the Netherlands and has a significant body of work in medicine, particularly in cardiology and cardiovascular medicine. Their research spans multiple subfields including cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, molecular biology, surgery, and oncology.

The scientist's main research topics cover a wide range of areas related to cardiovascular and metabolic health. These topics include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management
  • Cardiomyopathy and Myosin Studies
  • Pancreatic function and diabetes
  • Cardiac electrophysiology and arrhythmias
  • Cardiac pacing and defibrillation studies

Rudolf A. de Boer has been published extensively in several key scientific venues, including:

  • European Journal of Heart Failure
  • European Heart Journal
  • Circulation
  • JACC Heart Failure
  • Journal of the American College of Cardiology

Their recent papers reflect ongoing contributions to cardiovascular research and clinical guidelines. Notable recent publications include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2021, European Heart Journal)
  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2022, New England Journal of Medicine)
  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) (2022, European Heart Journal)
  • 2023 ESC Guidelines for the management of cardiomyopathies (2023, European Heart Journal)
  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2023, European Heart Journal)

Throughout their career, Rudolf A. de Boer has frequently collaborated with several other researchers. Regular co-authors include:

  • John J.V. McMurray
  • Pardeep S. Jhund
  • Scott D. Solomon
  • Felipe A. Martínez
  • Carolyn S.P. Lam

Overall, Rudolf A. de Boer's publication record and collaborative network indicate a sustained focus on clinical and translational research in cardiovascular disease and related metabolic disorders. Their work is characterized by engagement in guideline development, clinical trials, and studies addressing mechanisms and treatment strategies in heart failure and associated conditions.

Best Publications

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    Burkert Pieske;Carsten Tschöpe;Rudolf A de Boer;Alan G Fraser

  • Identification of seven loci affecting mean telomere length and their association with disease

    Veryan Codd;Christopher P Nelson;Eva Albrecht;Massimo Mangino

  • Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

    Rudolf A de Boer;Dirk J A Lok;Tiny Jaarsma;Peter O van der Meer

  • Galectin-3: a novel mediator of heart failure development and progression.

    Rudolf A. de Boer;Adriaan A. Voors;Pieter Muntendam;Wiek H. van Gilst

  • Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

    Frank P. Brouwers;Rudolf A. de Boer;Pim van der Harst;Adriaan A. Voors

  • Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

    Petar M. Seferović;Mark C. Petrie;Gerasimos S. Filippatos;Stefan D. Anker

  • Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology

    Petar M Seferovic;Piotr Ponikowski;Stefan D Anker;Johann Bauersachs

  • Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

    Christian Mueller;Kenneth McDonald;Rudolf A. de Boer;Alan Maisel

  • Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

    Alexander R. Lyon;Susan Dent;Susannah Stanway;Helena Earl

  • Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

    Sheryl L. Chow;Alan S. Maisel;Inder Anand;Biykem Bozkurt

  • Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.

    Ronald P. Stolk;Judith G. M. Rosmalen;Dirkje S. Postma;Rudolf A. de Boer

  • Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis

    Lili Yu;Willem P.T. Ruifrok;Maxi Meissner;Eelke M. Bos

  • Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: Evidence supporting the concept of arrhythmogenic cardiomyopathy

    Paul A. van der Zwaag;Ingrid A. W. van Rijsingen;Angeliki Asimaki;Jan D. H. Jongbloed

  • New gene functions in megakaryopoiesis and platelet formation

    Christian Gieger;Aparna Radhakrishnan;Ana Cvejic;Weihong Tang

  • The fibrosis marker galectin-3 and outcome in the general population.

    R. A. de Boer;D. J. van Veldhuisen;R. T. Gansevoort;A. C. Muller Kobold

  • Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

    Laurent Calvier;Maria Miana;Pascal Reboul;Victoria Cachofeiro

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

  • Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study

    Karani S Vimaleswaran;Karani S Vimaleswaran;Alana Cavadino;Diane J Berry;Rolf Jorde

  • Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction.

    Nona Sotoodehnia;Aaron Isaacs;Paul I W de Bakker;Marcus Dörr

Frequent Co-Authors

Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Wiek H. van Gilst
Wiek H. van Gilst University Medical Center Groningen
Pim van der Harst
Pim van der Harst University Medical Center Utrecht
Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Hans L. Hillege
Hans L. Hillege University Medical Center Groningen
Nilesh J. Samani
Nilesh J. Samani University of Leicester
Peter van der Meer
Peter van der Meer University Medical Center Groningen
Stephan J. L. Bakker
Stephan J. L. Bakker University Medical Center Groningen
Ron T. Gansevoort
Ron T. Gansevoort University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t just mean medical school. There’s a diverse range of online healthcare degrees available, opening doors to administrative, nursing, and leadership roles. Flexible online options are increasingly popular, especially for professionals balancing work, study, and family obligations.

For those interested in healthcare management, consider online MHA programs that hold prestigious CAHME accreditation. Registered Nurses wanting to further their education can enroll in online RN to BSN programs without clinicals. These programs offer a streamlined path to a higher degree without additional hands-on training requirements.

If your goal is to advance clinical expertise, there are both quickest DNP program options and easiest online DNP programs available entirely online. These programs allow you to elevate your practice with greater flexibility and potentially faster completion times.

Whether you seek direct patient care or leadership in healthcare systems, these online pathways can help you reach your goals and adapt to a rapidly changing industry.

Best Scientists Citing Rudolf A. de Boer

Trending Scientists

Recently Published Articles